Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

Open access
Springer, Simeon U, Chen, Chung-Hsin, Rodriguez Pena, Maria Del Carmen, Li, Lu, Douville, Christopher, Wang, Yuxuan, Cohen, Joshua David, Taheri, Diana, Silliman, Natalie, Schaefer, Joy, Ptak, Janine, Dobbyn, Lisa, Papoli, Maria, Kinde, Isaac, Afsari, Bahman, Tregnago, Aline C, Bezerra, Stephania M, VandenBussche, Christopher, Fujita, Kazutoshi, Ertoy, Dilek, Cunha, Isabela W, Yu, Lijia, Bivalacqua, Trinity J, Grollman, Arthur P, Diaz, Luis A, Karchin, Rachel, Danilova, Ludmila, Huang, Chao-Yuan, Shun, Chia-Tung, Turesky, Robert J, Yun, Byeong Hwa, Rosenquist, Thomas A, Pu, Yeong-Shiau, Hruban, Ralph H, Tomasetti, Cristian, Papadopoulos, Nickolas, Kinzler, Ken W, Vogelstein, Bert, Dickman, Kathleen G, Netto, George J · 2018 · eLife

Abstract

Current non-invasive approaches for detection of urothelial cancers are suboptimal. We developed a test to detect urothelial neoplasms using DNA recovered from cells shed into urine. UroSEEK incorporates massive parallel sequencing assays for mutations in 11 genes and copy number changes on 39 chromosome arms. In 570 patients at risk for bladder cancer (BC), UroSEEK was positive in 83% of those who developed BC. Combined with cytology, UroSEEK detected 95% of patients who developed BC. Of 56 patients with upper tract urothelial cancer, 75% tested positive by UroSEEK, including 79% of those with non-invasive tumors. UroSEEK detected genetic abnormalities in 68% of urines obtained from BC patients under surveillance who demonstrated clinical evidence of recurrence. The advantages of UroSEEK over cytology were evident in low-grade BCs; UroSEEK detected 67% of cases whereas cytology detected none. These results establish the foundation for a new non-invasive approach for detection of urothelial cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.32143

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 183

Metadata

Authors
Springer, S. U., Chen, C.-H., Rodriguez Pena, M. D. C., Li, L., Douville, C., Wang, Y., Cohen, J. D., Taheri, D., Silliman, N., Schaefer, J., Ptak, J., Dobbyn, L., Papoli, M., Kinde, I., Afsari, B., Tregnago, A. C., Bezerra, S. M., VandenBussche, C., Fujita, K., Ertoy, D., Cunha, I. W., Yu, L., Bivalacqua, T. J., Grollman, A. P., Diaz, L. A., Karchin, R., Danilova, L., Huang, C.-Y., Shun, C.-T., Turesky, R. J., Yun, B. H., Rosenquist, T. A., Pu, Y.-S., Hruban, R. H., Tomasetti, C., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Dickman, K. G., & Netto, G. J.
Venue
eLife
Published
2018-03-20
Volume
7
ISSN
2050-084X (ISSN-L)
OpenAlex
W2765964920
Cited by
183
References
8
FWCI
20.74
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. https://app.cochat.ai/papers/10.7554/elife.32143
The paper
Springer, S. U., Chen, C.-H., Rodriguez Pena, M. D. C., Li, L., Douville, C., Wang, Y., Cohen, J. D., Taheri, D., Silliman, N., Schaefer, J., Ptak, J., Dobbyn, L., Papoli, M., Kinde, I., Afsari, B., Tregnago, A. C., Bezerra, S. M., VandenBussche, C., Fujita, K., . . . Netto, G. J. (2018). Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. eLife. https://doi.org/10.7554/elife.32143

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.